Literature DB >> 25652086

Barrett's oesophagus length is established at the time of initial endoscopy and does not change over time: results from a large multicentre cohort.

Fouad J Moawad1, Patrick E Young1, Srinivas Gaddam2, Prashanth Vennalaganti3, Prashanthi N Thota4, John Vargo4, Brooks D Cash5, Gary W Falk6, Richard E Sampliner7, David Lieberman8, Prateek Sharma9.   

Abstract

OBJECTIVE: It is unclear whether Barrett's oesophagus (BO) length changes over time or whether the full length of the segment is established at the onset of disease recognition. The objectives of this study were to evaluate the association of age and BO length and to evaluate the changes in BO length over time.
DESIGN: This is a prospective, multicentre cohort study involving patients with BO from five centres. Patients were divided into groups based on the decade of initial diagnosis of BO. The mean BO length and the mean change in BO length were calculated for each age decade. The mean change in BO length was also calculated between the index endoscopy and the last surveillance endoscopy.
RESULTS: 3635 patients with BO were included in the study: 87.8% men, 92.8% Caucasians, mean age 60.9 years and mean BO length 3.5 cm. The mean change in BO length was 0.9 cm. The mean BO length did not significantly change for each age category: <30 years (4.6 cm), 30-39.9 years (3.2 cm), 40-49.9 years (3.1 cm), 50-59.9 years (3.1 cm), 60-69.9 years (3.6 cm), 70-79.7 (4.0 cm) and >80 years (4.5 cm), p=0.47. On subgroup analysis of patients with non-dysplastic BO who had at least 1 year of endoscopic follow up, there was a significant decrease in mean change in BO length across age categories ranging from +1.7 to -0.8 cm, p=0.03.
CONCLUSIONS: There was no significant difference in BO length by age category in decades. In addition, the change in BO length from index to follow-up endoscopy was similar among patients >30 years. These findings suggest that a patient's BO segment length attains its full extent by the time of the initial endoscopic examination. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  ACID-RELATED DISEASES; BARRETT'S CARCINOMA; BARRETT'S METAPLASIA; BARRETT'S OESOPHAGUS

Mesh:

Year:  2015        PMID: 25652086     DOI: 10.1136/gutjnl-2014-308552

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   31.793


  3 in total

Review 1.  Endoscopic risk factors for neoplastic progression in patients with Barrett's oesophagus.

Authors:  Angela Bureo Gonzalez; Jacques Jghm Bergman; Roos E Pouw
Journal:  United European Gastroenterol J       Date:  2016-03-02       Impact factor: 4.623

Review 2.  Pathogenesis and Cells of Origin of Barrett's Esophagus.

Authors:  Jianwen Que; Katherine S Garman; Rhonda F Souza; Stuart Jon Spechler
Journal:  Gastroenterology       Date:  2019-05-10       Impact factor: 22.682

3.  Lower Annual Rate of Progression of Short-Segment vs Long-Segment Barrett's Esophagus to Esophageal Adenocarcinoma.

Authors:  Nour Hamade; Sreekar Vennelaganti; Sravanthi Parasa; Prashanth Vennalaganti; Srinivas Gaddam; Manon C W Spaander; Sophie H van Olphen; Prashanthi N Thota; Kevin F Kennedy; Marco J Bruno; John J Vargo; Sharad Mathur; Brooks D Cash; Richard Sampliner; Neil Gupta; Gary W Falk; Ajay Bansal; Patrick E Young; David A Lieberman; Prateek Sharma
Journal:  Clin Gastroenterol Hepatol       Date:  2018-08-08       Impact factor: 11.382

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.